Symbols / BRIA $1.93 -0.52%
BRIA Chart
About
BrilliA Inc designs, manufactures, and sells ladies intimate apparel in North America, the European Union, the Asia Pacific, Latin America, the Middle East, and internationally. The company's products include active, shape, sleep, baby, and swim wear; bra and panties; lingerie; brassiere; bodysuits; dresses; tops; and other products under DIANA, Vanity Fair, Hanes, Wonderbra, Playtex, Bali, Maidenform, Jockey, Lands' End, fleur du mal, Kiki de Montparnasse, and Bra n Things brands. It sells through website, social media, and marketplace platforms like Shopee. The company was incorporated in 2023 and is based in Singapore.
Fundamentals
Scroll to Statements| Sector | Consumer Cyclical | Industry | Apparel Retail | Market Cap | 48.25M |
| Enterprise Value | 53.46M | Income | 2.81M | Sales | 64.39M |
| Book/sh | 0.59 | Cash/sh | 0.25 | Dividend Yield | 27.42% |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | 16.08 | Forward P/E | 8.04 | PEG | — |
| P/S | 0.75 | P/B | 3.27 | P/C | — |
| EV/EBITDA | 13.18 | EV/Sales | 0.83 | Quick Ratio | 1.70 |
| Current Ratio | 2.84 | Debt/Eq | 9.59 | LT Debt/Eq | — |
| EPS (ttm) | 0.12 | EPS next Y | 0.24 | EPS Growth | -28.90% |
| Revenue Growth | 13.80% | Earnings | — | ROA | 9.02% |
| ROE | 21.54% | ROIC | — | Gross Margin | 16.16% |
| Oper. Margin | 6.60% | Profit Margin | 4.37% | Shs Outstand | 25.00M |
| Shs Float | 5.92M | Short Float | 0.14% | Short Ratio | 0.85 |
| Short Interest | — | 52W High | 4.95 | 52W Low | 1.41 |
| Beta | — | Avg Volume | 12.05K | Volume | 2.54K |
| Target Price | $5.00 | Recom | Strong_buy | Prev Close | $1.94 |
| Price | $1.93 | Change | -0.52% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$5.00
Mean price target
2. Current target
$1.93
Latest analyst target
3. DCF / Fair value
$-4.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.93
Low
$5.00
High
$5.00
Mean
$5.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-08-29 | init | Alliance Global Partners | — → Buy | $5 |
- Aug Action: Will BRIA stock maintain growth story - Weekly Investment Recap & Reliable Breakout Stock Forecasts - Naître et grandir Sat, 07 Mar 2026 09
- BrilliA and Ai Sakura team up on Japan-focused athleisure line for 2026 - Stock Titan Mon, 23 Feb 2026 08
- BrilliA Inc (NYSEAMERICAN:BRIA) Sees Large Increase in Short Interest - MarketBeat hu, 26 Feb 2026 08
- Volume Summary: Will Schaeffler AG (SHA010) stock benefit from mergers - 2025 Market WrapUp & Weekly High Conviction Trade Ideas - Naître et grandir Sat, 07 Mar 2026 06
- BCTXZ - Briacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan ue, 03 Mar 2026 10
- BrilliA declares $0.133 per share cash dividend payable September 30 - Investing.com Wed, 03 Sep 2025 07
- BriaCell Stock Notches Best Day In 5 Years On Breast Cancer Data — Then Drops 10% After-Hours: What Went Wrong? - Stocktwits Wed, 14 Jan 2026 05
- BriaCell stock notches best day in 5 years on breast cancer data — then drops 10% after-hours: What went wrong? - MSN Wed, 14 Jan 2026 06
- BrilliA Inc (NYSEAMERICAN:BRIA) Short Interest Down 51.5% in January - MarketBeat hu, 12 Feb 2026 08
- 10:1 Share Consolidation: BriaCell Therapeutics Takes Strategic Step to Maintain Nasdaq Capital Market Status - Stock Titan hu, 21 Aug 2025 07
- Signal Recap: How MVIS stock compares to industry benchmarks - 2025 Retail Activity & Weekly Watchlist for Hot Stocks - Naître et grandir Sat, 07 Mar 2026 03
- BriaCell (Nasdaq: BCTX) targets 1H2026 topline data in Phase 3 MBC trial under Fast Track - Stock Titan ue, 09 Dec 2025 08
- 78-year-old breast cancer patient sees lung tumor vanish for 11 months - Stock Titan ue, 13 Jan 2026 08
- Breakthrough Cancer Treatment Mechanism: BriaCell and NCI Validate Novel Immunotherapy Platform in Major Study - Stock Titan ue, 26 Aug 2025 07
- “Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine - Stock Titan hu, 18 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -16.14K | -36.41K | 4.73K | -4.35K |
| TaxRateForCalcs | 0.22 | 0.18 | 0.17 | 0.17 |
| NormalizedEBITDA | 4.65M | 4.78M | 5.65M | 6.09M |
| TotalUnusualItems | -73.00K | -206.00K | 28.00K | -25.16K |
| TotalUnusualItemsExcludingGoodwill | -73.00K | -206.00K | 28.00K | -25.16K |
| NetIncomeFromContinuingOperationNetMinorityInterest | 2.82M | 3.28M | 4.35M | 4.78M |
| ReconciledDepreciation | 459.00K | 199.00K | 215.00K | 326.00 |
| ReconciledCostOfRevenue | 53.96M | 47.32M | 43.79M | 61.26M |
| EBITDA | 4.58M | 4.58M | 5.67M | 6.06M |
| EBIT | 4.12M | 4.38M | 5.46M | 5.84M |
| NetInterestIncome | -364.00K | -322.00K | -256.00K | -52.26K |
| InterestExpense | 500.00K | 387.00K | 215.00K | 52.26K |
| InterestIncome | 185.00K | 106.00K | 6.00K | |
| NormalizedIncome | 2.87M | 3.45M | 4.33M | 4.80M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 2.82M | 3.28M | 4.35M | 4.78M |
| TotalExpenses | 60.33M | 51.46M | 47.46M | 65.06M |
| RentExpenseSupplemental | 60.00K | 202.00K | 180.00K | |
| DilutedAverageShares | 22.50M | 22.50M | 20.00M | |
| BasicAverageShares | 22.50M | 22.50M | 20.00M | |
| DilutedEPS | 0.15 | 0.19 | 0.24 | |
| BasicEPS | 0.15 | 0.19 | 0.24 | |
| DilutedNIAvailtoComStockholders | 2.82M | 3.28M | 4.35M | 4.78M |
| NetIncomeCommonStockholders | 2.82M | 3.28M | 4.35M | 4.78M |
| NetIncome | 2.82M | 3.28M | 4.35M | 4.78M |
| MinorityInterests | -4.00K | -3.00K | -5.00K | -4.39K |
| NetIncomeIncludingNoncontrollingInterests | 2.82M | 3.28M | 4.36M | 4.79M |
| NetIncomeContinuousOperations | 2.82M | 3.28M | 4.36M | 4.79M |
| TaxProvision | 800.00K | 705.00K | 885.00K | 1.00M |
| PretaxIncome | 3.62M | 3.99M | 5.24M | 5.79M |
| OtherIncomeExpense | -78.00K | -192.00K | 32.00K | -22.25K |
| OtherNonOperatingIncomeExpenses | -5.00K | 14.00K | 4.00K | 2.91K |
| SpecialIncomeCharges | -4.00K | -236.00K | -18.00K | -25.16K |
| WriteOff | 4.00K | 236.00K | 18.00K | 25.16K |
| GainOnSaleOfSecurity | -69.00K | 30.00K | 46.00K | |
| NetNonOperatingInterestIncomeExpense | -364.00K | -322.00K | -256.00K | -52.26K |
| TotalOtherFinanceCost | 49.00K | 41.00K | 47.00K | |
| InterestExpenseNonOperating | 500.00K | 387.00K | 215.00K | 52.26K |
| InterestIncomeNonOperating | 185.00K | 106.00K | 6.00K | |
| OperatingIncome | 4.06M | 4.50M | 5.47M | 5.86M |
| OperatingExpense | 6.37M | 4.14M | 3.67M | 4.02M |
| OtherOperatingExpenses | 1.31M | 639.00K | 491.00K | 1.51M |
| OtherTaxes | 411.00K | 361.00K | 228.00K | |
| DepreciationAmortizationDepletionIncomeStatement | 459.00K | 199.00K | 215.00K | 222.02K |
| DepreciationAndAmortizationInIncomeStatement | 459.00K | 199.00K | 215.00K | 222.02K |
| DepreciationIncomeStatement | 459.00K | 199.00K | 215.00K | 222.02K |
| SellingGeneralAndAdministration | 4.19M | 2.94M | 2.73M | 2.30M |
| SellingAndMarketingExpense | 20.00K | 4.00K | 4.00K | |
| GeneralAndAdministrativeExpense | 4.17M | 2.93M | 2.73M | 2.30M |
| OtherGandA | 609.00K | 306.00K | 195.00K | |
| InsuranceAndClaims | 131.00K | 131.00K | 106.00K | |
| RentAndLandingFees | 60.00K | 202.00K | 180.00K | |
| SalariesAndWages | 3.37M | 2.29M | 2.25M | 2.30M |
| GrossProfit | 10.43M | 8.64M | 9.13M | 9.89M |
| CostOfRevenue | 53.96M | 47.32M | 43.79M | 61.03M |
| TotalRevenue | 64.39M | 55.96M | 52.93M | 70.92M |
| OperatingRevenue | 64.39M | 55.96M | 52.93M | 70.92M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 25.00M | 25.00M | 25.00M | 25.00M |
| ShareIssued | 25.00M | 25.00M | 25.00M | 25.00M |
| TotalDebt | 1.68M | 0.00 | ||
| TangibleBookValue | 18.06M | 8.09M | 6.50M | 8.63M |
| InvestedCapital | 18.06M | 8.09M | 6.50M | 8.63M |
| WorkingCapital | 16.66M | 7.15M | 6.49M | 8.62M |
| NetTangibleAssets | 18.06M | 8.09M | 6.50M | 8.63M |
| CapitalLeaseObligations | 1.68M | 0.00 | ||
| CommonStockEquity | 18.06M | 8.09M | 6.50M | 8.63M |
| TotalCapitalization | 18.06M | 8.09M | 6.50M | 8.63M |
| TotalEquityGrossMinorityInterest | 18.07M | 8.10M | 6.50M | 8.63M |
| MinorityInterest | 16.00K | 12.00K | ||
| StockholdersEquity | 18.06M | 8.09M | 6.50M | 8.63M |
| GainsLossesNotAffectingRetainedEarnings | -6.09M | -6.06M | ||
| OtherEquityAdjustments | -5.91M | -5.91M | ||
| ForeignCurrencyTranslationAdjustments | -180.00K | -144.00K | ||
| RetainedEarnings | 10.30M | 7.49M | 6.50M | 8.63M |
| CapitalStock | 13.85M | 6.66M | 100.00 | 100.00 |
| CommonStock | 13.85M | 6.66M | 100.00 | 100.00 |
| TotalLiabilitiesNetMinorityInterest | 10.33M | 19.05M | 15.71M | 16.30M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.30M | 0.00 | 0.00 | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 1.30M | 0.00 | ||
| LongTermCapitalLeaseObligation | 1.30M | 0.00 | ||
| CurrentLiabilities | 9.04M | 19.05M | 15.71M | 16.30M |
| OtherCurrentLiabilities | -50.00 | |||
| CurrentDebtAndCapitalLeaseObligation | 382.00K | |||
| CurrentCapitalLeaseObligation | 382.00K | 0.00 | ||
| PayablesAndAccruedExpenses | 8.65M | 19.05M | 15.71M | 16.30M |
| CurrentAccruedExpenses | 1.40M | 1.35M | 1.64M | 2.10M |
| Payables | 7.25M | 17.70M | 14.06M | 14.20M |
| OtherPayable | 506.00K | 7.65M | 7.12M | 3.45M |
| DuetoRelatedPartiesCurrent | 180.00K | 57.00K | 8.17K | 99.54K |
| TotalTaxPayable | 3.27M | 2.36M | 1.68M | 858.69K |
| IncomeTaxPayable | 3.08M | 2.31M | 1.68M | 858.69K |
| AccountsPayable | 3.29M | 7.62M | 5.26M | 9.79M |
| TotalAssets | 28.41M | 27.15M | 22.20M | 24.93M |
| TotalNonCurrentAssets | 2.72M | 952.00K | 3.62K | 4.94K |
| NonCurrentDeferredAssets | 0.00 | 837.00K | 0.00 | |
| InvestmentsAndAdvances | 1.00M | 0.00 | ||
| InvestmentinFinancialAssets | 1.00M | 0.00 | ||
| FinancialAssetsDesignatedasFairValueThroughProfitorLossTotal | 1.00M | 0.00 | ||
| NetPPE | 1.72M | 115.00K | 3.62K | 4.94K |
| AccumulatedDepreciation | -644.00K | -209.00K | -3.48K | -2.16K |
| GrossPPE | 2.36M | 324.00K | 7.10K | 7.10K |
| OtherProperties | 115.00K | |||
| MachineryFurnitureEquipment | 381.00K | 324.00K | 7.10K | 7.10K |
| BuildingsAndImprovements | 1.98M | 0.00 | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 25.69M | 26.20M | 22.20M | 24.92M |
| PrepaidAssets | 2.83M | 5.58M | 5.13M | 4.61M |
| Inventory | 7.28M | 7.09M | 5.73M | 9.74M |
| FinishedGoods | 2.54M | 2.86M | 2.49M | 4.19M |
| WorkInProcess | 1.57M | 1.02M | 627.48K | 1.20M |
| RawMaterials | 3.17M | 3.22M | 2.61M | 4.35M |
| Receivables | 7.88M | 7.14M | 2.43M | 6.21M |
| OtherReceivables | 26.00K | 31.00K | ||
| DuefromRelatedPartiesCurrent | 235.00K | 459.00K | 100.00K | 0.00 |
| TaxesReceivable | 67.00K | 59.00K | ||
| AccountsReceivable | 7.55M | 6.59M | 2.33M | 6.21M |
| AllowanceForDoubtfulAccountsReceivable | -283.00K | -279.00K | -42.83K | -25.16K |
| GrossAccountsReceivable | 7.83M | 6.87M | 2.37M | 6.24M |
| CashCashEquivalentsAndShortTermInvestments | 7.70M | 6.38M | 8.91M | 4.36M |
| CashAndCashEquivalents | 7.70M | 6.38M | 8.91M | 4.36M |
| CashEquivalents | 6.10M | |||
| CashFinancial | 1.61M | 8.91M | 4.36M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| FreeCashFlow | -4.59M | 87.00K | 11.07M | 3.59M |
| RepaymentOfDebt | -361.00K | -202.00K | -206.00K | |
| IssuanceOfCapitalStock | 7.19M | 0.00 | 0.00 | |
| CapitalExpenditure | -72.00K | -57.00K | -9.00K | -4.89K |
| EndCashPosition | 7.70M | 6.38M | 9.05M | 4.36M |
| BeginningCashPosition | 6.38M | 9.05M | 4.90M | 5.75M |
| EffectOfExchangeRateChanges | 18.00K | -106.00K | -38.00K | |
| ChangesInCash | 1.30M | -2.56M | 4.19M | -1.39M |
| FinancingCashFlow | 6.71M | -2.75M | -6.89M | -4.97M |
| CashFlowFromContinuingFinancingActivities | 6.71M | -2.75M | -6.89M | -4.97M |
| NetOtherFinancingCharges | -2.00K | 612.00K | -351.00K | -3.67M |
| InterestPaidCFF | -116.00K | -9.00K | -31.00K | |
| CashDividendsPaid | 0.00 | -3.15M | -6.30M | -1.30M |
| CommonStockDividendPaid | 0.00 | -3.15M | -6.30M | -1.30M |
| NetCommonStockIssuance | 7.19M | 0.00 | 0.00 | |
| CommonStockIssuance | 7.19M | 0.00 | 0.00 | |
| NetIssuancePaymentsOfDebt | -361.00K | -202.00K | -206.00K | |
| NetLongTermDebtIssuance | -361.00K | -202.00K | -206.00K | |
| LongTermDebtPayments | -361.00K | -202.00K | -206.00K | |
| InvestingCashFlow | -887.00K | 49.00K | -3.00K | -4.89K |
| CashFlowFromContinuingInvestingActivities | -887.00K | 49.00K | -3.00K | -4.89K |
| InterestReceivedCFI | 185.00K | 106.00K | 6.00K | |
| NetInvestmentPurchaseAndSale | -1.00M | 0.00 | 0.00 | |
| PurchaseOfInvestment | -1.00M | 0.00 | 0.00 | |
| NetPPEPurchaseAndSale | -72.00K | -57.00K | -9.00K | -4.89K |
| PurchaseOfPPE | -72.00K | -57.00K | -9.00K | -4.89K |
| OperatingCashFlow | -4.52M | 144.00K | 11.08M | 3.59M |
| CashFlowFromContinuingOperatingActivities | -4.52M | 144.00K | 11.08M | 3.59M |
| TaxesRefundPaid | -33.00K | -198.00K | -124.00K | |
| ChangeInWorkingCapital | -8.50M | -3.98M | 5.70M | -1.64M |
| ChangeInOtherWorkingCapital | 837.00K | -837.00K | ||
| ChangeInPayablesAndAccruedExpense | -11.17M | 3.38M | -1.53M | 1.94M |
| ChangeInPayable | -11.17M | 3.38M | -1.53M | 1.94M |
| ChangeInInventory | -187.00K | -1.36M | 4.00M | 339.65K |
| ChangeInReceivables | 2.02M | -5.17M | 3.23M | -3.92M |
| OtherNonCashItems | -69.00K | -97.00K | 25.00K | |
| AssetImpairmentCharge | 4.00K | 236.00K | 18.00K | 25.16K |
| DepreciationAmortizationDepletion | 459.00K | 199.00K | 215.00K | 326.00 |
| DepreciationAndAmortization | 459.00K | 199.00K | 215.00K | 326.00 |
| Depreciation | 459.00K | 199.00K | 215.00K | 326.00 |
| NetIncomeFromContinuingOperations | 3.62M | 3.99M | 5.24M | 5.20M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for BRIA
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|